

Methyltestosterone, sold under the brand names Android, Metandren, and Testred among others, is an androgen and anabolic steroid (AAS) medication which is used in the treatment of low testosterone levels in men, delayed puberty in boys, at low doses as a component of menopausal hormone therapy for menopausal symptoms like hot flashes, osteoporosis, and low sexual desire in women, and to treat breast cancer in women. It is taken by mouth.
The global market for Methyltestosterone was estimated to be worth US$ 185 million in 2023 and is forecast to a readjusted size of US$ 294.5 million by 2030 with a CAGR of 6.4% during the forecast period 2024-2030
North American market for Methyltestosterone was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Methyltestosterone was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Methyltestosterone was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Methyltestosterone include Impax Laboratories, Bausch Health and HARBIN PHARMACEUTICAL GROUP, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Methyltestosterone, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Methyltestosterone by region & country, by Type, and by Application.
The Methyltestosterone market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Methyltestosterone.
Market Segmentation
By Company
Impax Laboratories
Bausch Health
HARBIN PHARMACEUTICAL GROUP
Segment by Type:
Capsules
Tablets
Segment by Application
Low Testosterone Levels in Men
Delayed Puberty in Boys
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Methyltestosterone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Methyltestosterone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Methyltestosterone in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Methyltestosterone Product Introduction
1.2 Global Methyltestosterone Market Size Forecast
1.2.1 Global Methyltestosterone Sales Value (2019-2030)
1.2.2 Global Methyltestosterone Sales Volume (2019-2030)
1.2.3 Global Methyltestosterone Sales Price (2019-2030)
1.3 Methyltestosterone Market Trends & Drivers
1.3.1 Methyltestosterone Industry Trends
1.3.2 Methyltestosterone Market Drivers & Opportunity
1.3.3 Methyltestosterone Market Challenges
1.3.4 Methyltestosterone Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Methyltestosterone Players Revenue Ranking (2023)
2.2 Global Methyltestosterone Revenue by Company (2019-2024)
2.3 Global Methyltestosterone Players Sales Volume Ranking (2023)
2.4 Global Methyltestosterone Sales Volume by Company Players (2019-2024)
2.5 Global Methyltestosterone Average Price by Company (2019-2024)
2.6 Key Manufacturers Methyltestosterone Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Methyltestosterone Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Methyltestosterone
2.9 Methyltestosterone Market Competitive Analysis
2.9.1 Methyltestosterone Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Methyltestosterone Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Methyltestosterone as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Capsules
3.1.2 Tablets
3.2 Global Methyltestosterone Sales Value by Type
3.2.1 Global Methyltestosterone Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Methyltestosterone Sales Value, by Type (2019-2030)
3.2.3 Global Methyltestosterone Sales Value, by Type (%) (2019-2030)
3.3 Global Methyltestosterone Sales Volume by Type
3.3.1 Global Methyltestosterone Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Methyltestosterone Sales Volume, by Type (2019-2030)
3.3.3 Global Methyltestosterone Sales Volume, by Type (%) (2019-2030)
3.4 Global Methyltestosterone Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Low Testosterone Levels in Men
4.1.2 Delayed Puberty in Boys
4.2 Global Methyltestosterone Sales Value by Application
4.2.1 Global Methyltestosterone Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Methyltestosterone Sales Value, by Application (2019-2030)
4.2.3 Global Methyltestosterone Sales Value, by Application (%) (2019-2030)
4.3 Global Methyltestosterone Sales Volume by Application
4.3.1 Global Methyltestosterone Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Methyltestosterone Sales Volume, by Application (2019-2030)
4.3.3 Global Methyltestosterone Sales Volume, by Application (%) (2019-2030)
4.4 Global Methyltestosterone Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Methyltestosterone Sales Value by Region
5.1.1 Global Methyltestosterone Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Methyltestosterone Sales Value by Region (2019-2024)
5.1.3 Global Methyltestosterone Sales Value by Region (2025-2030)
5.1.4 Global Methyltestosterone Sales Value by Region (%), (2019-2030)
5.2 Global Methyltestosterone Sales Volume by Region
5.2.1 Global Methyltestosterone Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Methyltestosterone Sales Volume by Region (2019-2024)
5.2.3 Global Methyltestosterone Sales Volume by Region (2025-2030)
5.2.4 Global Methyltestosterone Sales Volume by Region (%), (2019-2030)
5.3 Global Methyltestosterone Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Methyltestosterone Sales Value, 2019-2030
5.4.2 North America Methyltestosterone Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Methyltestosterone Sales Value, 2019-2030
5.5.2 Europe Methyltestosterone Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Methyltestosterone Sales Value, 2019-2030
5.6.2 Asia Pacific Methyltestosterone Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Methyltestosterone Sales Value, 2019-2030
5.7.2 South America Methyltestosterone Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Methyltestosterone Sales Value, 2019-2030
5.8.2 Middle East & Africa Methyltestosterone Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Methyltestosterone Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Methyltestosterone Sales Value
6.2.1 Key Countries/Regions Methyltestosterone Sales Value, 2019-2030
6.2.2 Key Countries/Regions Methyltestosterone Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Methyltestosterone Sales Value, 2019-2030
6.3.2 United States Methyltestosterone Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Methyltestosterone Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Methyltestosterone Sales Value, 2019-2030
6.4.2 Europe Methyltestosterone Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Methyltestosterone Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Methyltestosterone Sales Value, 2019-2030
6.5.2 China Methyltestosterone Sales Value by Type (%), 2023 VS 2030
6.5.3 China Methyltestosterone Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Methyltestosterone Sales Value, 2019-2030
6.6.2 Japan Methyltestosterone Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Methyltestosterone Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Methyltestosterone Sales Value, 2019-2030
6.7.2 South Korea Methyltestosterone Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Methyltestosterone Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Methyltestosterone Sales Value, 2019-2030
6.8.2 Southeast Asia Methyltestosterone Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Methyltestosterone Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Methyltestosterone Sales Value, 2019-2030
6.9.2 India Methyltestosterone Sales Value by Type (%), 2023 VS 2030
6.9.3 India Methyltestosterone Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Impax Laboratories
7.1.1 Impax Laboratories Company Information
7.1.2 Impax Laboratories Introduction and Business Overview
7.1.3 Impax Laboratories Methyltestosterone Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Impax Laboratories Methyltestosterone Product Offerings
7.1.5 Impax Laboratories Recent Development
7.2 Bausch Health
7.2.1 Bausch Health Company Information
7.2.2 Bausch Health Introduction and Business Overview
7.2.3 Bausch Health Methyltestosterone Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Bausch Health Methyltestosterone Product Offerings
7.2.5 Bausch Health Recent Development
7.3 HARBIN PHARMACEUTICAL GROUP
7.3.1 HARBIN PHARMACEUTICAL GROUP Company Information
7.3.2 HARBIN PHARMACEUTICAL GROUP Introduction and Business Overview
7.3.3 HARBIN PHARMACEUTICAL GROUP Methyltestosterone Sales, Revenue and Gross Margin (2019-2024)
7.3.4 HARBIN PHARMACEUTICAL GROUP Methyltestosterone Product Offerings
7.3.5 HARBIN PHARMACEUTICAL GROUP Recent Development
8 Industry Chain Analysis
8.1 Methyltestosterone Industrial Chain
8.2 Methyltestosterone Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Methyltestosterone Sales Model
8.5.2 Sales Channel
8.5.3 Methyltestosterone Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Impax Laboratories
Bausch Health
HARBIN PHARMACEUTICAL GROUP
Ìý
Ìý
*If Applicable.